- Home
- CVAC vs GETY Comparison
CVAC vs GETY Comparison
Compare CVAC & GETY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- GETY
- Stock Information
- Founded
- CVAC 2000
- GETY 1995
- Country
- CVAC Germany
- GETY United States
- Employees
- CVAC N/A
- GETY N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- GETY Industrial Machinery/Components
- Sector
- CVAC Health Care
- GETY Industrials
- Exchange
- CVAC Nasdaq
- GETY Nasdaq
- Market Cap
- CVAC 764.4M
- GETY 723.5M
- IPO Year
- CVAC 2020
- GETY N/A
- Fundamental
- Price
- CVAC $5.40
- GETY $1.72
- Analyst Decision
- CVAC Hold
- GETY Hold
- Analyst Count
- CVAC 3
- GETY 5
- Target Price
- CVAC $6.83
- GETY $4.35
- AVG Volume (30 Days)
- CVAC 2.1M
- GETY 1.3M
- Earning Date
- CVAC 08-14-2025
- GETY 08-08-2025
- Dividend Yield
- CVAC N/A
- GETY N/A
- EPS Growth
- CVAC N/A
- GETY N/A
- EPS
- CVAC 0.87
- GETY N/A
- Revenue
- CVAC $566,039,775.00
- GETY $941,086,000.00
- Revenue This Year
- CVAC N/A
- GETY $2.71
- Revenue Next Year
- CVAC $24.04
- GETY $2.74
- P/E Ratio
- CVAC $6.22
- GETY N/A
- Revenue Growth
- CVAC 787.60
- GETY 4.20
- 52 Week Low
- CVAC $2.37
- GETY $1.25
- 52 Week High
- CVAC $5.72
- GETY $4.49
- Technical
- Relative Strength Index (RSI)
- CVAC 64.78
- GETY 47.35
- Support Level
- CVAC $5.33
- GETY $1.60
- Resistance Level
- CVAC $5.58
- GETY $1.78
- Average True Range (ATR)
- CVAC 0.12
- GETY 0.10
- MACD
- CVAC -0.04
- GETY -0.00
- Stochastic Oscillator
- CVAC 23.81
- GETY 32.26
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About GETY Getty Images Holdings Inc.
Getty Images Holdings Inc. is a visual content creator and marketplace that offers a full range of content solutions. Through its Getty Images, Stock, and Unsplash brands, websites, and APIs, it serves customers around the world by allowing them to discover, purchase, and share visual content from photographers, illustrators, image partners, and videographers. The company generates a majority of its revenue through subscriptions, offering various subscription products on the Getty Images, iStock, and Unsplash websites. It operates and manages one operating segment, which is the business of developing and commercializing visual content. Geographically, the company generates maximum revenue from the Americas, followed by Europe, the Middle East and Africa, and the Asia-Pacific region.